+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Merck & Co., Inc. - logo

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

Metastatic Bone Disease - Global Strategic Business Report 2026 - Product Thumbnail Image

Metastatic Bone Disease - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 237 Pages
  • Global
From
Angiosarcoma Treatment - Global Strategic Business Report - Product Thumbnail Image

Angiosarcoma Treatment - Global Strategic Business Report

  • Report
  • November 2026
  • 390 Pages
  • Global
From
From
Ewing Sarcoma - Global Strategic Business Report - Product Thumbnail Image

Ewing Sarcoma - Global Strategic Business Report

  • Report
  • November 2026
  • 377 Pages
  • Global
From
From
Conjugate Vaccine Market Report 2026 - Product Thumbnail Image

Conjugate Vaccine Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Adult Vaccines Market Report 2026 - Product Thumbnail Image

Adult Vaccines Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Ruminant Feed Antibiotics Market Report 2026 - Product Thumbnail Image

Ruminant Feed Antibiotics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Diabetic Nephropathy Treatment Market - Global Forecast 2026-2032 - Product Thumbnail Image

Diabetic Nephropathy Treatment Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 186 Pages
  • Global
From
From
From
From
Esophageal Cancer Drugs - Global Strategic Business Report 2026 - Product Thumbnail Image

Esophageal Cancer Drugs - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 269 Pages
  • Global
From
From
From
Retinoblastoma Treatment - Global Strategic Business Report 2026 - Product Thumbnail Image

Retinoblastoma Treatment - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 279 Pages
  • Global
From
Stomach Cancer Treatment - Global Strategic Business Report 2026 - Product Thumbnail Image

Stomach Cancer Treatment - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 371 Pages
  • Global
From
Hepatocellular Carcinoma - Global Clinical Trials Review, 2026 - Product Thumbnail Image

Hepatocellular Carcinoma - Global Clinical Trials Review, 2026

  • Clinical Trials
  • July 2026
  • 3337 Pages
  • Global
From
Loading Indicator